Article Text

Download PDFPDF
Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study
  1. R H Arnold,
  2. E Kotlyar,
  3. C Hayward,
  4. A M Keogh,
  5. P S Macdonald
  1. Heart and Lung Transplant Unit, St Vincent’s Hospital, and Victor Chang Cardiac Research Institute, Sydney, Australia
  1. Correspondence to:
    Dr Peter Macdonald, Heart and Lung Transplant Unit, St Vincent’s Hospital, Darlinghurst, NSW, Australia 2010;
    pmacdonald{at}stvincents.com.au

Abstract

Objective: To determine whether the process of reverse left ventricular remodelling in response to carvedilol is dependent on baseline heart rate (BHR), heart rhythm, or heart rate reduction (HRR) in response to carvedilol.

Design: Retrospective analysis of serial echocardiograms in 257 patients with chronic systolic heart failure at baseline and at 12–18 months after starting carvedilol. Reverse left ventricular remodelling was determined by changes in left ventricular end diastolic dimension (LVEDD), end systolic dimension (LVESD), and fractional shortening (LVFS).

Setting: Heart failure clinic within a university teaching hospital.

Main outcome measures: Changes in LVEDD, LVESD, and LVFS.

Results: LVEDD and LVESD decreased by 2.6 (0.4) mm and 4.9 (0.5) mm, respectively (mean (SEM)), and LVFS increased by 4.3 (0.5)% (all p < 0.0001 v baseline). Simple regression revealed no significant relation between BHR or HRR and the changes in LVEDD, LVESD, or LVFS. Stratification of patients into high and low BHR groups (above and below the mean) or according to the baseline heart rhythm (sinus rhythm v atrial fibrillation) showed no differences between groups in the extent of reverse left ventricular remodelling. Improvements in left ventricular function and dimensions were associated with significant improvements in New York Heart Association functional class.

Conclusions: The benefits of carvedilol in terms of reverse left ventricular remodelling and symptomatic improvement in patients with chronic heart failure are independent of BHR, heart rhythm, and the HRR that occurs in response to carvedilol.

  • β blocker
  • carvedilol
  • heart failure
  • remodelling
  • BHR, baseline heart rate
  • CIBIS, cardiac insufficiency bisoprolol study
  • HRR, heart rate reduction
  • LVEDD, left ventricular end diastolic dimension
  • LVESD, left ventricular end systolic dimension
  • LVFS, left ventricular fractional shortening
  • MERIT, metoprolol CR/XL randomised intervention trial
  • NYHA, New York Heart Association

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes